114 related articles for article (PubMed ID: 7965274)
1. Effects of renin-angiotensin system in mediating endothelin-induced renal vasoconstriction: therapeutic implications.
Chan DP; Clavell A; Keiser J; Burnett JC
J Hypertens Suppl; 1994 Jul; 12(4):S43-9. PubMed ID: 7965274
[TBL] [Abstract][Full Text] [Related]
2. Effects of quinapril on angiotensin converting enzyme and plasma renin activity as well as pharmacokinetic parameters of quinapril and its active metabolite, quinaprilat, after intravenous and oral administration to mature horses.
Davis JL; Kruger K; LaFevers DH; Barlow BM; Schirmer JM; Breuhaus BA
Equine Vet J; 2014 Nov; 46(6):729-33. PubMed ID: 24175935
[TBL] [Abstract][Full Text] [Related]
3. Local angiotensin-converting enzyme inhibition blunts endothelin-1-induced increase in forearm vascular resistance.
Abernethy DR; Laurie N; Andrawis NS
Clin Pharmacol Ther; 1995 Sep; 58(3):328-34. PubMed ID: 7554707
[TBL] [Abstract][Full Text] [Related]
4. The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system.
Humke U; Levens N; Wood J; Hofbauer K
J Pharmacol Exp Ther; 1992 Jan; 260(1):29-35. PubMed ID: 1309874
[TBL] [Abstract][Full Text] [Related]
5. Effects of the angiotensin-converting enzyme inhibitor quinapril on renal function in rats.
Graziano MJ; Dethloff LA; Griffin HE; Pegg DG
Arch Int Pharmacodyn Ther; 1993; 324():87-104. PubMed ID: 8297189
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of endothelin on renin release in dog kidneys.
Naess PA; Christensen G; Kiil F
Acta Physiol Scand; 1993 Jun; 148(2):131-6. PubMed ID: 8102503
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system.
Säynävälammi P; Pörsti I
Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510
[TBL] [Abstract][Full Text] [Related]
8. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
Major TC; Overhiser RW; Taylor DG; Panek RL
J Pharmacol Exp Ther; 1993 Apr; 265(1):187-93. PubMed ID: 8474005
[TBL] [Abstract][Full Text] [Related]
9. The effect of renin-angiotensin system blockade on visceral blood flow during and after thoracic aortic cross-clamping.
Joob AW; Harman PK; Kaiser DL; Kron IL
J Thorac Cardiovasc Surg; 1986 Mar; 91(3):411-8. PubMed ID: 3005777
[TBL] [Abstract][Full Text] [Related]
10. Renal and hemodynamic effects of endothelin in anesthetized dogs.
Tsuchiya K; Naruse M; Sanaka T; Naruse K; Zeng ZP; Nitta K; Demura H; Shizume K; Sugino N
Am J Hypertens; 1990 Oct; 3(10):792-5. PubMed ID: 2222945
[TBL] [Abstract][Full Text] [Related]
11. Renal actions of endothelin: interaction with prostacyclin.
Chou SY; Dahhan A; Porush JG
Am J Physiol; 1990 Oct; 259(4 Pt 2):F645-52. PubMed ID: 2221102
[TBL] [Abstract][Full Text] [Related]
12. Action of endothelin-1 on glomerular haemodynamics in the dog: lack of direct effects on glomerular ultrafiltration coefficient.
Heller J; Kramer HJ; Horacek V
Clin Sci (Lond); 1996 May; 90(5):385-91. PubMed ID: 8665776
[TBL] [Abstract][Full Text] [Related]
13. Chronic endothelin-induced pressor and renal actions in conscious dogs do not require altered ANG II formation.
Wilkins FC; Kassab S; Kato T; Mizelle HL; Opgenorth TJ; Granger JP
Am J Physiol; 1995 Feb; 268(2 Pt 2):R395-402. PubMed ID: 7864234
[TBL] [Abstract][Full Text] [Related]
14. Intrarenal infusions of endothelin in conscious dogs: interactions with prostanoids and angiotensin II.
Anderson WP; Heguilen RM; Woods RL
J Cardiovasc Pharmacol; 1995 Oct; 26(4):511-7. PubMed ID: 8569208
[TBL] [Abstract][Full Text] [Related]
15. Contribution of endothelin to renal vascular tone and autoregulation in the conscious dog.
Berthold H; Münter K; Just A; Kirchheim HR; Ehmke H
Am J Physiol; 1999 Mar; 276(3):F417-24. PubMed ID: 10070165
[TBL] [Abstract][Full Text] [Related]
16. Effects of renal arterial endothelin-1 and endogenous endothelins on regional kidney blood flow and renal antihypertensive mechanisms in anesthetized rabbits.
Weekes SR; Madden AC; Bergström G; Anderson WP; Evans RG
Kidney Blood Press Res; 2000; 23(6):366-75. PubMed ID: 11070416
[TBL] [Abstract][Full Text] [Related]
17. Effects of the calcium channel antagonist nicardipine on renal action of endothelin in dogs.
Yukimura T; Miura K; Yamashita Y; Shimmen T; Okumura M; Yamanaka S; Saito M; Yamamoto K
Contrib Nephrol; 1991; 90():105-10. PubMed ID: 1959334
[TBL] [Abstract][Full Text] [Related]
18. Endothelin has biological actions at pathophysiological concentrations.
Lerman A; Hildebrand FL; Aarhus LL; Burnett JC
Circulation; 1991 May; 83(5):1808-14. PubMed ID: 2022031
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of the renin-angiotensin system by endothelin subtype A receptor blockade in conscious dogs.
Berthold H; Münter K; Just A; Kirchheim HR; Ehmke H
Hypertension; 1999 Jun; 33(6):1420-4. PubMed ID: 10373226
[TBL] [Abstract][Full Text] [Related]
20. Determinants of the renal response to ACE inhibition in patients with congestive heart failure.
Gottlieb SS; Robinson S; Weir MR; Fisher ML; Krichten CM
Am Heart J; 1992 Jul; 124(1):131-6. PubMed ID: 1615796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
